
Ajooni Biotech Reports Q1 Results for FY 2026; Net Profit Stands at 43.18 Lakhs
Ajooni Biotech Limited announced the outcomes of its Board meeting held on August 14, 2026, approving the unaudited financial results and the limited review report for the quarter ended June 30, 2026. The company's performance during the period saw total income from operations stand at 6,375.96 Lakhs.The Board considered and approved the un-audited Financial Results and the Limited Review Report from the auditor for the financial quarter ending June 30, 2026.
Q1 FY 2026 Financial Performance Highlights
Key financial figures for Ajooni Biotech Limited for the quarter ended June 30, 2026, compared to the previous two periods are detailed below (figures in Lakhs):| Metric | Quarter Ended 30.06.2026 | Quarter Ended 31.03.2026 | Year Ended 30.06.2025 |
|---|---|---|---|
| Revenue from Operations | 6,349.07 | 6,062.21 | 3,126.77 |
| Total Income from Operations | 6,375.96 | 6,192.64 | 3,191.31 |
| Cost of Material Consumed | 5,454.86 | 2,564.17 | 14,805.33 |
| Profit/(Loss) before exceptional items and tax | 65.44 | 112.03 | 573.83 |
| Net Profit/(Loss) for the period | 43.18 | 94.72 | 432.19 |
Financial Position as of June 30, 2026
The company's financial position showed assets totaling 4,181.02 Lakhs. Equity and liabilities detailed in the statement include:| Particulars | Amount (Lakhs) |
|---|---|
| Paid-up equity share capital | 3,444.87 |
| Other equity (excluding revaluation reserve) | 5,717.45 |
| Total Assets | 4,181.02 |
Auditor's Limited Review Report
The company's unaudited financial results for the period ending June 30, 2026, were subjected to a limited review by Chartered Accountants. The review was conducted in accordance with the Standard on Review Engagement (SRE) 2400 of the Institute of Chartered Accountants of India.The auditor's report concluded that nothing came to their attention that suggests material misstatement or lack of required disclosure in the unaudited financial results, which were prepared according to applicable accounting standards and recognized practices.
AJOONI Stock Price Movement
Today, shares of Ajooni Biotech Limited edged higher to close at ₹3.86, recording a strong gain of 3.18%. The stock witnessed solid interest during the session, registering a traded volume of 302,997 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.